FMR1 and fragile X syndrome: Although Ctnnb1 amount is reported to be reduced in adult NPCs derived from Fmr1 KO mouse [50], NPCs derived from human embryonic stem cells established from FXS patients showed unchanged Ctnnb1 level compared to the nonaffected control [51].